NU.Q
LIVE

Serial Number

79260744

Owner

Belgian Volition SPRL

Attorney

Megan Michaels

Filing Date

Apr 3, 2019

Add to watchlist:

No watchlists yet
View on USPTO

NU.Q Trademark

Serial Number: 79260744 • Registration: 6044605

NU.Q is a trademark filed by Belgian Volition SPRL on April 3, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Belgian Volition SPRL

Rue Phocas Lejeune 22

Entity Type: 78

Trademark Details

Filing Date

April 3, 2019

Registration Date

May 5, 2020

Published for Opposition

February 18, 2020

Goods & Services

Surgical, medical and diagnostic apparatus and instruments, namely, cancer diagnostic apparatus and instruments, medical apparatus for use in cancer surgery; diagnostic measuring apparatus for medical use, namely, diagnostic measuring apparatus for detecting cellular status; medical apparatus, instruments and equipment for use in the detection of cancer; in vitro diagnostic testing apparatus for medical use; in vitro diagnostic testing apparatus incorporating chemical reagents, for medical use; medical apparatus for testing blood; medical apparatus, instruments and equipment for use in the detection of disease; parts and fittings for all the aforesaid

Chemicals used in industry and science; chemicals and other chemical preparations used in diagnostics for scientific or research use; chemical reagents for use in industry and science; chemical, biological and diagnostic reagents for scientific or research use, preparations and substances for scientific, diagnostic and research purposes, namely reagent, cells, enzymes; chemical and biological preparations and reagents for use in diagnostic and analytical tests, including in vitro diagnostic laboratory tests; in vitro diagnostics preparations, diagnostic reagents for in vitro laboratory use; reagents for life science scientific purposes

Scientific and technological services, namely scientific testing and analysis in the field of the detection, diagnosis and treatment of cancer; industrial analysis of industrial fluids and industrial research services in the field of the detection, diagnosis and treatment of cancer; research and development, consultancy and advisory services relating to biotechnology, medical technology, medical diagnostic assays, medical diagnostics, medical diagnostic reagents, substances, preparations and materials, detection of cancer and other diseases; analytical testing and diagnostic services, namely providing medical testing services and computer diagnostic services, all in the field of cancer research and disease classification; design and development of medical diagnostic testing apparatus and reagents; blood analysis services; information, advisory, and consultancy services relating to all the aforesaid

Pharmaceutical and diagnostic products and preparations, namely, pharmaceutical products for the treatment of cancer and cancer diagnostic preparations for medical purposes; medical diagnostic testing materials, namely, test strips for use in the field of cancer, reagents and assays for testing bodily fluids for cancer; diagnostic reagents for medical use; diagnostic reagents, namely, reagents for medicinal use; diagnostic reagents for medical use; medical preparations for detection and diagnosis of cancer; medical preparations for detection and diagnosis of inflammation; stem cell differentiation status test preparations for medical purposes in the field of cancer diagnosis, testing, and treatment; chemical, biological and diagnostic reagents and preparations for medical purposes in the field of cancer diagnosis, testing, and treatment; medical preparations for detection and diagnosis of diseases

Filing History

TEAS SECTION 71 RECEIVED
Apr 30, 2026 ES71
NEW REPRESENTATIVE AT IB RECEIVED
Nov 13, 2025 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 5, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 3, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 11, 2020 FICS
FINAL DISPOSITION PROCESSED
Sep 11, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 5, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
May 5, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 18, 2020 NPUB
PUBLISHED FOR OPPOSITION
Feb 18, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Feb 14, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 29, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 29, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 29, 2020 NONP
ASSIGNED TO LIE
Jan 16, 2020 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 14, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 13, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 13, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 13, 2020 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Dec 20, 2019 NREP
REFUSAL PROCESSED BY IB
Aug 2, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 12, 2019 RFCS
REFUSAL PROCESSED BY MPU
Jul 12, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 25, 2019 RFCR
NON-FINAL ACTION WRITTEN
Jun 24, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Jun 22, 2019 MAFR
ASSIGNED TO EXAMINER
Jun 18, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 18, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 13, 2019 REPR